BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Aug 01, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Azilect rasagiline regulatory update

FDA's Peripheral and Central Nervous System Drugs Advisory Committee will meet on Oct. 17 to discuss an sNDA from Teva for Azilect rasagiline to slow to clinical progression in patients with...

Read the full 131 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >